| Literature DB >> 33066429 |
Paulina Kęska1, Karolina M Wójciak1, Dariusz M Stasiak1.
Abstract
The present study assessed the effect of pretreating beef as a raw material for sous vide steak preparation. The pretreatment involved maceration of a batch of meat in sour milk with the simultaneous use of ultrasound (250 or 500 W) as well as the addition of Taraxacum officinale. The biological activity profile of the peptides was assessed in terms of their antioxidant activity and inhibiting activity against angiotensin-converting enzyme (ACE). Changes in the biological activity of peptides under the influence of hydrolysis by gastrointestinal enzymes, i.e., pepsin and pancreatin, were also considered. There was no significant effect of T. officinale addition and sonication of beef batches on the protein content (except for lot S6, after sonication at 500 W as acoustic power and with the addition of dandelion). It was observed that the interaction of maceration in sour milk with simultaneous ultrasound treatment as the initial production step of sous vide beef steak generates the formation of peptides with antioxidant properties. Moreover, peptide formation can be further enhanced by adding dandelion (based on the results of antiradical and chelating activity tests). In addition, the progression of hydrolysis under the influence of gastrointestinal enzymes promotes the release of peptides with antioxidant and anti-ACE activity.Entities:
Keywords: ACE inhibitor; antioxidant; beef; bioactive peptides; dandelion; sonication
Mesh:
Substances:
Year: 2020 PMID: 33066429 PMCID: PMC7587380 DOI: 10.3390/molecules25204692
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1Protein and peptide content (µg mL−1) during in vitro hydrolysis of cooked beef steaks.
Amino acid content in sous vide beef steak (mg kg−1).
| Amino Acid | S1 | S2 | S3 | S4 | S5 | S6 |
|---|---|---|---|---|---|---|
|
| ||||||
| His | 0.019 ± 0.003 a | 0.047 ± 0.012 b | 0.027 ± 0.003 ab | 0.041 ± 0.014 ab | 0.024 ± 0.004 ab | 0.034 ± 0.009 ab |
| Thr | 0.016 ± 0.010 a | 0.039 ± 0.012 a | 0.021 ± 0.010 a | 0.032 ± 0.010 a | 0.028 ± 0.004 a | 0.031 ± 0.008 a |
| Val | 0.037 ± 0.009 a | 0.078 ± 0.016 b | 0.053 ± 0.004 ab | 0.076 ± 0.021 ab | 0.056 ± 0.011 ab | 0.071 ± 0.019 ab |
| Met | 0.024 ± 0.005 a | 0.031 ± 0.010 a | 0.024 ± 0.005 a | 0.032 ± 0.013 a | 0.029 ± 0.003 a | 0.030 ± 0.012 a |
| Lys | 0.039 ± 0.005 a | 0.091 ± 0.032 a | 0.053 ± 0.004 a | 0.082 ± 0.033 a | 0.047 ± 0.004 a | 0.071 ± 0.031 a |
| Ile | 0.028 ± 0.008 a | 0.051 ± 0.012 a | 0.034 ± 0.005 a | 0.047 ± 0.018 a | 0.037 ± 0.006 a | 0.049 ± 0.01 a |
| Leu | 0.060 ± 0.011 a | 0.105 ± 0.025 a | 0.079 ± 0.004 a | 0.104 ± 0.037 a | 0.086 ± 0.010 a | 0.109 ± 0.029 a |
| Phe | 0.035 ± 0.015 a | 0.064 ± 0.014 a | 0.044 ± 0.003 a | 0.066 ± 0.022 a | 0.054 ± 0.009 a | 0.061 ± 0.010 a |
|
| ||||||
| Asp | 0.002 ± 0.003 a | 0.010 ± 0.005 a | 0.004 ± 0.003 a | 0.005 ± 0.004 a | 0.009 ± 0.010 a | 0.017 ± 0.008 a |
| Ser | 0.027 ± 0.009 a | 0.055 ± 0.011 a | 0.030 ± 0.013 a | 0.053 ± 0.023 a | 0.046 ± 0.005 a | 0.055 ± 0.019 a |
| Glu | 0.305 ± 0.097 a | 0.527 ± 0.050 a | 0.431 ± 0.054 a | 0.488 ± 0.182 a | 0.401 ± 0.033 a | 0.380 ± 0.121 a |
| Gly | 0.035 ± 0.015 a | 0.049 ± 0.006 a | 0.039 ± 0.001 a | 0.047 ± 0.016 a | 0.048 ± 0.005 a | 0.042 ± 0.010 a |
| Pro | n.d. | 0.136 ± 0.036 a | n.d. | 0.142 ± 0.076 a | n.d. | 0.110 ± 0.047 a |
| Ala | 0.139 ± 0.044 a | 0.213 ± 0.021 a | 0.173 ± 0.011 a | 0.214 ± 0.072 a | 0.189 ± 0.016 a | 0.174 ± 0.042 a |
| Arg | 0.028 ± 0.011 a | 0.068 ± 0.019 b | 0.023 ± 0.002 a | 0.030 ± 0.013 a | 0.034 ± 0.011 a | 0.051 ± 0.007 ab |
| Cys | n.d. | 0.009 ± 0.016 | n.d. | n.d. | n.d. | n.d. |
| Tyr | 0.030 ± 0.014 a | 0.051 ± 0.024 a | 0.037 ± 0.011 a | 0.053 ± 0.017 a | 0.058 ± 0.015 a | 0.046 ± 0.025 a |
| EAA/NEAA ratio | 0.466 ± 0.061 a | 0.456 ± 0.089 a | 0.457 ± 0.055 a | 0.478 ± 0.124 a | 0.460 ± 0.054 a | 0.524 ± 0.025 a |
|
| ||||||
| 1mHis | 0.257 ± 0.074 a | 0.246 ± 0.036 a | 0.273 ± 0.065 a | 0.297 ± 0.061 a | 0.278 ± 0.053 a | 0.201 ± 0.0238 a |
| GABA | n.d. | 0.021 ± 0.004 a | n.d. | 0.013 ± 0.004 a | n.d. | 0.015 ± 0.004 a |
| Eta | 0.000 ± 0.000 a | 0.023 ± 0.003 bc | 0.012 ± 0.003 b | 0.018 ± 0.005 bc | 0.016 ± 0.002 bc | 0.027 ± 0.007 c |
| Orn | 0.003 ± 0.005 a | 0.006 ± 0.011 a | 0.020 ± 0.003 a | 0.028 ± 0.009 a | 0.012 ± 0.012a | 0.008 ± 0.011 a |
| Tau | 0.090 ± 0.007 a | 0.156 ± 0.044 a | 0.131 ± 0.045 a | 0.142 ± 0.046 a | 0.154 ± 0.043 a | 0.114 ± 0.021 a |
a–c Within the same sample (column), mean values followed by the common letter do not differ significantly (p < 0.05). n.d.—not detected. S1—sample marinated in sour milk; S2—sample marinated in sour milk and with addition of herbs; S3—sample after ultrasonoud (250 W) treatment and marinated in sour milk; S4—sample after ultrasonoud (250 W) treatment and marinated in sour milk and with addition of herbs; S5—sample after ultrasonoud (500 W) treatment and marinated in sour milk; S6—sample after ultrasonoud (500 W) treatment and marinated in sour milk and with addition of herbs. His—histidine, Thr—threonine; Val—valine; Met—methionine; Lys—lysine; Ile—isoleucine; Leu—leucine; Phe—phenylalanine; Asp—aspartic acid; Ser—serine; Glu—glutamic acid; Gly—glycine; Pro—proline; (Gly), Ala—alanine; Arg—arginine; Cys—cysteine; Tyr—tyrosine; 1mHis—1-methylhistidine; GABA—γ-aminobutyric acid; Eta—ethanolamine; Orn—ornithine, Tau—taurine.
Figure 2The SDS-PAGE profile of proteins from beef steak obtained before hydrolysis (A), after pepsin hydrolysis (B) and after pepsin-pancreatin in vitro hydrolysis (C). M—molecular weight marker; SC—control samples; S1–S6—analyzed samples.
Protein digestibility (%) from sous vide beef steak after hydrolysis with gastrointestinal enzymes.
| Sample | Pepsin Hydrolysates | Pepsin/Pancreatin Hydrolysates | Sample (S) | Treatment (T) | S × T |
|---|---|---|---|---|---|
| S1 | 72.09 ± 5.17 Aab | 94.63 ± 2.12 Bac | *** | *** | * |
| S2 | 73.13 ± 4.30 Aa | 85.61 ± 5.51 Bb | |||
| S3 | 63.51 ± 3.41 Ab | 90.37 ± 5.16 Babc | |||
| S4 | 72.84 ± 9.63 Aab | 86.97 ± 4.79 Bb | |||
| S5 | 71.65 ± 4.56 Aab | 89.07 ± 3.95 Bab | |||
| S6 | 72.84 ± 4.12 Aa | 92.18 ± 1.70 Bab | |||
| SC | 78.07 ± 2.40 Aa | 96.03 ± 1.18 Bc |
a–c Within the same sample (column), mean values followed by the common letter do not differ significantly (p < 0.05). A,B Within the proteolytic treatment (row), mean values followed by the common letter do not differ significantly (p < 0.05); mean ± standard deviation; *** (p < 0.001), * (p < 0.05).
Results of radical scavenging activity against ABTS•+ (%).
| Sample | Nondigested Extract | Pepsin Hydrolysate | Pepsin/Pancreatin Hydrolysate | Sample (S) | Treatment (T) | S × T |
|---|---|---|---|---|---|---|
| S1 | 39.11 ± 5.54 Aa | 33.33 ± 3.22 Aa | 87.33 ± 2.17 Ba | *** | *** | *** |
| S2 | 51.35 ± 4.15 Ab | 44.44 ± 2.68 Bb | 98.72 ± 0.38 Cb | |||
| S3 | 49.37 ± 5.12 Ab | 13.40 ± 2.58 Bc | 85.36 ± 0.70 Ca | |||
| S4 | 66.21 ± 5.14 Ac | 41.73 ± 6.82 Bb | 97.99 ± 1.01 Cb | |||
| S5 | 49.47 ± 4.36 Ab | 30.32 ± 0.98 Ba | 79.68 ± 1.39 Cc | |||
| S6 | 64.52 ± 3.26 Ac | 41.63 ± 4.59 Bb | 96.63 ± 2.99 Cb | |||
| SC | 72.81 ± 2.00 Ac | 55.60 ± 2.53 Bd | 99.01 ± 0.71 Cb |
a–d Within the same batches (column), mean values followed by the common letter do not differ significantly (p < 0.05). A–C Within the proteolytic treatment (row), mean values followed by the common letter do not differ significantly (p < 0.05). Mean ± standard deviation. *** (p < 0.001).
Results of Fe2+chelating activity (%).
| Sample | Nondigested Extract | Pepsin Hydrolysate | Pepsin/Pancreatin Hydrolysate | Sample (S) | Treatment (T) | S × T |
|---|---|---|---|---|---|---|
| S1 | 17.97 ± 0.165 Aa | 33.45 ± 1.35 Ba | 82.65 ± 0.24 Ca | *** | *** | *** |
| S2 | 38.31 ± 3.22 Ab | 31.77 ± 2.24 Ba | 66.61 ± 0.65 Cb | |||
| S3 | 26.37 ± 2.02 Acd | 17.85 ± 1.17 Bb | 83.50 ± 0.83 Ca | |||
| S4 | 24.82 ± 2.85 Ad | 11.57 ± 3.55 Bb | 77.48 ± 0.25 Cc | |||
| S5 | 27.72 ± 2.48 Ad | 13.61 ± 3.39 Bb | 88.19 ± 0.97 Cd | |||
| S6 | 33.08 ± 0.43 Abc | 17.75 ± 3.20 Bb | 84.26 ± 1.13 Ca | |||
| SC | 10.34 ± 2.99 Ae | 17.43 ± 0.96 Bb | 75.61 ± 1.24 Cc |
a–e Within the same batches (column), mean values followed by the common letter do not differ significantly (p < 0.05). A–C Within the proteolytic treatment (row), mean values followed by the common letter do not differ significantly (p < 0.05). Mean ± standard deviation. *** (p < 0.001).
Results of reducing power (A700).
| Sample | Nondigested Extract | Pepsin Hydrolysate | Pepsin/Pancreatin Hydrolysate | Sample (S) | Treatment (T) | S × T |
|---|---|---|---|---|---|---|
| S1 | 0.317 ± 0.053 Aa | 0.832 ± 0.048 Ba | 0.333 ± 0.057 Aa | *** | *** | *** |
| S2 | 0.630 ± 0.042 Ab | 0.824 ± 0.053 Ba | 0.414 ± 0.071 Cb | |||
| S3 | 0.343 ± 0.048 Aac | 0.723 ± 0.096 Bab | 0.338 ± 0.047 Aa | |||
| S4 | 0.579 ± 0.087 Abd | 1.084 ± 0.174 Bc | 0.417 ± 0.055 Aab | |||
| S5 | 0.420 ± 0.038 Ac | 0.904 ± 0.058 Bad | 0.201 ± 0.017 Cc | |||
| S6 | 0.551 ± 0.021 Ad | 1.022 ± 0.067 Bcd | 0.233 ± 0.029 Cc | |||
| SC | 0.572 ± 0.033 Abd | 0.648 ± 0.063 Bb | 0.330 ± 0.035 Ca |
a–d Within the same batches (column), mean values followed by the common letter do not differ significantly (p < 0.05). A–C Within the proteolytic treatment (row), mean values followed by the common letter do not differ significantly (p < 0.05). Mean± standard deviation. *** (p < 0.001).
Results of angiotensin-converting enzyme (ACE-I) inhibiting activity (%).
| Sample | Nondigested Extract | Pepsin Hydrolysate | Pepsin/Pancreatin Hydrolysate | Sample (S) | Treatment (T) | S × T |
|---|---|---|---|---|---|---|
| S1 | 40.54 ± 1.85 Aa | 42.41 ± 1.92 Aa | 43.69 ± 1.72 Aa | *** | *** | *** |
| S2 | 39.21± 1.10 Aa | 51.70 ± 2.26 Bb | 44.11 ± 0.90 Ca | |||
| S3 | 42.39 ± 1.68 Aa | 43.92 ± 2.66 Aa | 40.37 ± 0.52 Ab | |||
| S4 | 44.61 ± 1.34 Abc | 54.32 ± 2.46 Bb | 47.97 ± 1.04 Ac | |||
| S5 | 43.72± 1.92 Aac | 52.17 ± 1.92 Bb | 43.57 ± 1.19 Aa | |||
| S6 | 43.33 ± 0.24 Aab | 52.09 ± 0.74 Bb | 49.51 ± 0.95 Cc | |||
| SC | 47.28 ± 1.86 Ac | 61.17 ± 1.66 Bc | 57.32 ± 1.46 Cd |
a–d Within the same batches (column), mean values followed by the common letter do not differ significantly (p < 0.05). A–C Within the proteolytic treatment (row), mean values followed by the common letter do not differ significantly (p < 0.05). Mean ± standard deviation. *** (p < 0.001).
Details of the experimental tests.
| Sample | Treatment |
|---|---|
| S1 | marinated in sour milk |
| S2 | marinated in sour milk + addition of herbs |
| S3 | ultrasonic level I + marinated in sour milk |
| S4 | ultrasonic level I + marinated in sour milk + addition of herbs |
| S5 | ultrasonic level II + marinated in sour milk |
| S6 | ultrasonic level II + marinated in sour milk + addition of herbs |
| SC | control sample (raw meat) |